Hematology & Oncology Doctors in Edgewood, KY Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Dr. John C Winkelmann, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Matthew Paul Kurian, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Dr. Douglas B Flora, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Manish S. Bhandari, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Dr. Lawrence V Brennan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Dr. William G Danneman, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

Daniel B Flora, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000    Fax: 859-301-4001

News Archive

Drinking alcohol regularly in your 40's increases risk of mild cognitive impairment

People in their 40's who drink alcohol regularly could be increasing their risk of mild cognitive impairment, a precursor to dementia and Alzheimer's. The claim is reported in the current issue of the British Medical Journal.

OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee's annual meeting

Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the annual meeting of the Foundation for National Institute for Health Biomarker Consortium Cancer Steering Committee, held in Washington, DC on 6-7 November 2017.

Researchers report new gene delivery method that targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.

New software may help improve major deficiencies in ADHD children

An intensive, five-week working memory training program shows promise in relieving some of the symptoms of attention deficit hyperactivity disorder in children, a new study suggests.

Read more Medical News

› Verified 7 days ago